Post-approval studies (Phase 4)Looking for participantsNCT07323524What this trial is testingDapagliflozin in Active Lupus NephritisWho this might be right forLupus Nephritis (LN) Brigham and Women's Hospital 33
Not applicableStudy completedNCT05890131What this trial is testingImplementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital StrategyWho this might be right forHeart Failure Morten Schou 5,996
Post-approval studies (Phase 4)Study completedNCT04642261What this trial is testingEffect of Empagliflozin on Liver Fat in Non-diabetic PatientsWho this might be right forNon-alcoholic Fatty Liver Disease The University of Hong Kong 98
Testing effectiveness (Phase 2)Study completedNCT03922750What this trial is testingA Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin GlargineWho this might be right forDiabetes Mellitus, Type 2 Novo Nordisk A/S 154
Post-approval studies (Phase 4)Study completedNCT03982381What this trial is testingSGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 DiabetesWho this might be right forType 2 Diabetes Uppsala University 2,067
Not applicableUnknownNCT03917758What this trial is testingAntidiuretic Function Before and During Treatment With SGLT2 InhibitorsWho this might be right forDiabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes University of Turin, Italy 30
Not applicableLooking for participantsNCT06271200What this trial is testingStrategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)Who this might be right forMetabolic Syndrome National Health Research Institutes, Taiwan 200
Post-approval studies (Phase 4)Looking for participantsNCT07292909What this trial is testingEffect of Empagliflozin on InflammationWho this might be right forCAD - Coronary Artery DiseaseInflamationPCI+1 more Hotel Dieu de France Hospital 100
Not applicableNot Yet RecruitingNCT06739486What this trial is testingEfficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver DiseaseWho this might be right forNon Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more Assiut University 100
Not applicableStudy completedNCT06288529What this trial is testingEFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURYWho this might be right forChronic Kidney DiseasesType2diabetes University of Health Sciences Balikesir Hospital Eduation and Research 975
Post-approval studies (Phase 4)Study completedNCT06268977What this trial is testingAdding SGLt2 Inhibitors to Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Assiut University 482
Large-scale testing (Phase 3)Study completedNCT03087773What this trial is testingImpact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial InfarctionWho this might be right forAcute Myocardial Infarction Medical University of Graz 476
Not applicableEnded earlyNCT05341388What this trial is testingThe Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 DiabetesWho this might be right forType2 DiabetesCognitive Impairment Goztepe Training and Research Hospital 25
Not applicableStudy completedNCT05640180What this trial is testingAn Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study ResultsWho this might be right forChronic Kidney DiseaseType 2 Diabetes Bayer 17,847
Post-approval studies (Phase 4)Ended earlyNCT05737186What this trial is testingSGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal InsufficiencyWho this might be right forHeart Failure With Reduced Ejection FractionRenal Insufficiency, Chronic Peking University People's Hospital 11
Testing effectiveness (Phase 2)Looking for participantsNCT07336797What this trial is testingEffect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based TherapyWho this might be right forMetabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus) Abdelrahman Mahmoud 66
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435What this trial is testingBeta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor AgonistsWho this might be right forType 2 Diabetes (T2DM) MaryAnn Banerji 60
Testing effectiveness (Phase 2)Study completedNCT03951805What this trial is testingA Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin BeforeWho this might be right forDiabetes Mellitus, Type 2 Novo Nordisk A/S 205
Post-approval studies (Phase 4)Active Not RecruitingNCT03878459What this trial is testingDapagliflozin Plus Pioglitazone in T1DMWho this might be right forType 1 Diabetes Mellitus The University of Texas Health Science Center at San Antonio 120
Post-approval studies (Phase 4)Study completedNCT03267576What this trial is testingAn Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on MetforminWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 64